AGL 40.15 Increased By ▲ 0.02 (0.05%)
AIRLINK 193.50 Increased By ▲ 4.07 (2.15%)
BOP 10.09 Decreased By ▼ -0.25 (-2.42%)
CNERGY 7.02 Decreased By ▼ -0.19 (-2.64%)
DCL 10.23 Increased By ▲ 0.02 (0.2%)
DFML 40.60 Decreased By ▼ -1.20 (-2.87%)
DGKC 105.62 Decreased By ▼ -3.01 (-2.77%)
FCCL 37.81 Decreased By ▼ -0.78 (-2.02%)
FFBL 92.39 Increased By ▲ 2.48 (2.76%)
FFL 14.86 Decreased By ▼ -0.16 (-1.07%)
HUBC 121.94 Decreased By ▼ -1.29 (-1.05%)
HUMNL 14.26 Decreased By ▼ -0.19 (-1.31%)
KEL 6.17 Decreased By ▼ -0.17 (-2.68%)
KOSM 8.22 Decreased By ▼ -0.18 (-2.14%)
MLCF 47.89 Decreased By ▼ -1.58 (-3.19%)
NBP 74.05 Decreased By ▼ -0.77 (-1.03%)
OGDC 215.45 Increased By ▲ 2.04 (0.96%)
PAEL 33.10 Increased By ▲ 0.11 (0.33%)
PIBTL 9.36 Increased By ▲ 0.29 (3.2%)
PPL 196.50 Decreased By ▼ -3.43 (-1.72%)
PRL 33.50 Decreased By ▼ -1.05 (-3.04%)
PTC 26.80 Decreased By ▼ -0.41 (-1.51%)
SEARL 115.00 Decreased By ▼ -3.19 (-2.7%)
TELE 9.64 Decreased By ▼ -0.24 (-2.43%)
TOMCL 35.47 Increased By ▲ 0.05 (0.14%)
TPLP 11.98 Decreased By ▼ -0.59 (-4.69%)
TREET 22.82 Increased By ▲ 0.53 (2.38%)
TRG 61.00 Increased By ▲ 0.10 (0.16%)
UNITY 35.99 Decreased By ▼ -0.70 (-1.91%)
WTL 1.81 Increased By ▲ 0.02 (1.12%)
BR100 12,105 Decreased By -60.2 (-0.5%)
BR30 37,565 Decreased By -215.2 (-0.57%)
KSE100 113,569 Decreased By -611.5 (-0.54%)
KSE30 35,499 Decreased By -202.2 (-0.57%)
World

Pfizer-BioNTech to provide 1bn vaccines to poorer nations this year

  • "Pfizer and BioNTech are pledging to provide 2 billion doses of our COVID-19 vaccines to middle- and low-income countries over the next 18 months," Albert Bourla told a global health summit.
Published May 21, 2021

BRUSSELS: Pfizer and BionTech pledged on Friday to deliver 1 billion doses of their COVID-19 vaccine to poorer nations this year and another 1 billion next year, the boss of Pfizer said.

"Pfizer and BioNTech are pledging to provide 2 billion doses of our COVID-19 vaccines to middle- and low-income countries over the next 18 months," Albert Bourla told a global health summit.

Comments

Comments are closed.